Related Experiment Video
Updated: Aug 16, 2025
Invasive Hemodynamic Assessment for the Right Ventricular System and Hypoxia-Induced Pulmonary Arterial Hypertension in Mice
Published on: October 24, 2019
Bmpr2 mutant mice are an inadequate model for studying iron deficiency in pulmonary hypertension
Vida Zhang1,2, Tomas Ganz1, Elizabeta Nemeth1
1Department of Medicine David Geffen School of Medicine, UCLA Los Angeles California USA.
Abstract:
As bone morphogenetic protein receptor type II (Bmpr2) mutations are the most common genetic cause of pulmonary arterial hypertension (PAH), and iron deficiency (ID) is associated with worse clinical outcomes in PAH patients, we proposed to use Bmpr2 ± mice to induce a model of ID in pulmonary vascular disease. Our study shows that these transgenic mice are not a good model for this clinical phenomenon.
Insights
Bone morphogenetic protein receptor type II (Bmpr2) mutations are linked to pulmonary arterial hypertension (PAH). Researchers found that Bmpr2 ± mice are not a suitable model for studying iron deficiency (ID) in PAH.
Area of Science:
- Cardiovascular Biology
- Genetics
- Pulmonary Medicine
Background:
- Mutations in bone morphogenetic protein receptor type II (Bmpr2) are the primary genetic cause of pulmonary arterial hypertension (PAH).
- Iron deficiency (ID) is recognized as a factor correlating with poorer clinical outcomes in patients diagnosed with PAH.
Purpose of the Study:
- To evaluate the utility of Bmpr2 ± mice as a model for investigating iron deficiency (ID) in the context of pulmonary vascular disease.
- To determine if Bmpr2 ± transgenic mice accurately replicate the clinical phenomenon of ID in pulmonary arterial hypertension.
Main Methods:
- Utilized Bmpr2 ± transgenic mice to create a model system.
- Induce iron deficiency in the pulmonary vascular disease model.
Main Results:
- The study demonstrated that Bmpr2 ± transgenic mice do not effectively model the clinical condition of iron deficiency in pulmonary arterial hypertension.
- These mice were found to be unsuitable for studying the interplay between Bmpr2 mutations, iron deficiency, and pulmonary vascular disease.
Conclusions:
- Bmpr2 ± mice are not an appropriate preclinical model for studying iron deficiency in pulmonary arterial hypertension.
- Further research is needed to develop accurate animal models that reflect the clinical complexities of PAH with associated iron deficiency.
